Loading...
IVVD INVIVYD INC US FDA Inspections 8-K Filing
Back
NVVY
VVD
INVIVYD INC
(IVVD)
Follow
FY2024 8 K
View More
Back
NVVY
VVD
INVIVYD INC
(IVVD)
Follow
FY2024 8 K
Filing:
8 K
Published on:
3 Jan '24
Financial Statements
15 May '25
Product Expansion
12 May '25
Failure to Meet Listing Sta...
25 Apr '25
Loan Agreement
21 Apr '25
Director Appointment
26 Mar '25
Financial Results
20 Mar '25
Product Update
5 Mar '25
Nasdaq Compliance
24 Feb '25
Q4 2024 Results
3 Feb '25
FDA EUA Update
27 Jan '25
PEMGARDA Update
10 Jan '25
Nasdaq Notice
27 Dec '24
Director Resignation
2 Dec '24
Financial Results
14 Nov '24
Q3 2024 Results
29 Oct '24
Virology Data Release
23 Sep '24
Corporate Update
6 Sep '24
Clinical Trial Launch
4 Sep '24
PEMGARDA Update
3 Sep '24
COVID-19 Treatment Update
27 Aug '24
Financial Results
14 Aug '24
Announcement
14 Jun '24
Management Changes
31 May '24
Annual Meeting of Stockholders
22 May '24
Financial Results and Corpo...
9 May '24
Other Events
7 May '24
Departure of CEO and Appoin...
12 Apr '24
Other Events
4 Apr '24
Financial Results Announcement
28 Mar '24
Press Release
22 Mar '24
Departure of Director, Refi...
9 Feb '24
Other Events
8 Jan '24
Other Special Situation
3 Jan '24
Sales Agreement
22 Dec '23
Clinical Trial Results
18 Dec '23
Financial Results Announcement
9 Nov '23
Other Events
11 Sep '23
Earnings Report
10 Aug '23
Appointment of Director
27 Jul '23
Other Events
29 Jun '23
Amendment to Certificate of...
25 May '23
Financial Results Announcement
11 May '23
Incentive Program Approval
2 May '23
Financial Results Announcement
23 Mar '23
Announcement of COVID-19 th...
6 Mar '23
Other Events
9 Jan '23
External Links:
SEC
AI Assistant
Close
INVIVYD INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.